Drug Profile
Berupipam
Alternative Names: NNC 220010Latest Information Update: 19 Feb 1999
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Class Antipsychotics; Small molecules
- Mechanism of Action Dopamine D1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 19 Feb 1999 Discontinued-I for Psychotic disorders in USA (PO)
- 13 Nov 1995 Phase-I clinical trials for Psychotic disorders in USA (PO)